Boronate Affinity LC-MS Detection of Sialylated CGMP in PKU Formula

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting casein glycomacropeptide (CGMP) in special medical formula food for phenylketonuria patients are not suitable due to the complex matrix of food samples, which includes additives like oils and vitamins, leading to reduced ionization efficiency and inaccurate detection of sialic acid-containing CGMP.

Innovation Solution

A boronate affinity column (BAC) using phenylboronic acid modified mesoporous silica is employed for selective adsorption and elution of sialic acid-containing CGMP, combined with liquid chromatography-tandem mass spectrometry (LC-MS) to achieve sensitive and rapid detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If complex polypeptide samples are directly detected by LC-MS, then the analysis can be performed quickly, but the coexistence of peptides and proteins reduces ionization efficiency and thus reduces the response value

Engineering Contradiction:
Improveanalysis speedVSAvoidionization efficiency
Core Design Contradiction:
SpeedVSMeasurement precision

Solution Approach 1:

The patent applies preliminary action by performing boronate affinity column enrichment before LC-MS analysis. The phenylboric acid column selectively binds glycopeptides containing sialic acid, concentrating the target analyte and removing interfering proteins and peptides from the sample matrix. This pre-concentration step ensures sufficient ionization efficiency while maintaining rapid analysis capability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent extracts the target glycopeptides from the complex sample matrix using boronate affinity chromatography. The phenylboric acid group on the column selectively interacts with the cis-o-diol structure on glycopeptides, extracting and isolating these compounds from the mixture of proteins and peptides, thereby eliminating ionization suppression effects.

Inventive Principle:
Principle #2Taking out (Extraction)

2Quantity of substance

If conventional boronate affinity column methods are used for CGMP enrichment, then glycopeptide enrichment can be achieved, but the method is not suitable for food samples with complex matrix including oils, vitamins, and additives

Engineering Contradiction:
Improveglycopeptide enrichmentVSAvoidapplicability to food samples
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The patent modifies the boronate affinity column parameters by using phenylboric acid modified silica spheres with specific particle size (2-50 μm) and optimizing the mobile phase composition. The method adjusts pH conditions and solvent selection to accommodate the complex food matrix, enabling successful enrichment of CGMP from phenylketonuria formula food despite the presence of oils, vitamins, and additives.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If phenylboric acid modified silica spheres with particle size of 2-50 μm are used, then glycopeptide enrichment is achieved, but the method requires organic solvents and neutral pH which are not suitable for CGMP in PKU formula food

Engineering Contradiction:
Improveglycopeptide enrichmentVSAvoidsuitability for food sample analysis
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent applies local quality by optimizing specific parameters of the boronate affinity column for food sample analysis. The phenylboric acid modified silica spheres are designed with specific particle size distribution and surface properties that enable selective binding of CGMP while accommodating the complex food matrix. The method develops specific mobile phase conditions (organic solvent content and pH) that are compatible with both the column chemistry and the food sample composition.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides selective and efficient detection of sialic acid-containing CGMP in phenylketonuria formula food, overcoming issues of impurities and matrix complexity, enabling accurate quantification and structural analysis.

Implementation Method 1

the phenylboric acid group on the boronate affinity column has a special affinity for the cis-o-diol structure on the glycopeptides, which can achieve the enrichment and purification of glycopeptides

Methodology Applied
Scientific EffectBoronate affinity: Adsorption

Implementation Method 2

Liquid chromatography-tandem mass spectrometry (LC-MS) has high sensitivity and accuracy in the analysis of polypeptides

Methodology Applied
Scientific EffectIonization: Ionisation

Data Source

PatentUS12553868B2Kind of method for detecting sialoglycosyl casein glycomacropeptide
Publication Date: 2026.02.17 JIANGNAN UNIV
  • US12553868B2 patent drawing
  • US12553868B2 patent drawing
  • US12553868B2 patent drawing

AI summary

The invention discloses a method for the detection of sialate glycosyl casein glycomacropeptide by boronate affinity column enrichment-liquid chromatography-tandem mass spectrometry using phenylboric acid modified mesoporous silica as packing material, which belongs to the field of food analysis and detection. The method includes the following steps: (1) sample preparation; (2) enrichment and purification of boronate affinity column; (3) liquid chromatography-tandem mass spectrometry detection. The invention makes use of the affinity property of phenylboric acid to the special sugar group sialic acid on the serine and threonine residues in casein glycogiant peptide, regulates the adsorption and elution of casein glycogiant peptide with sialic acid group by changing pH. Combined with the high sensitivity and accuracy of liquid chromatography tandem mass spectrometry, it can be used for qualitative and quantitative analysis of casein glycomacropeptide with sialate glycol-group in phenylketonuria special medical formulations with complex matrix.